Staphylococcus aureus is a leading cause of human disease in the hospital setting and the community. Superantigenic toxin-producing methicillin-resistant Staphylococcus aureus (MRSA) is currently important for nosocomial infections and food-borne diseases worldwide because of its global spreading and difficulty in therapy. Superantigenic toxins can bypass normal antigen presentation and have strong T cell mitogenic activity, leading to massive release of proinflammatory cytokines and contributing to the severity of S. aureus sepsis. In this study, a total of 131 MRSA isolates from patients in the University Hospital were searched for staphylococcal cassette chromosome mec (SCCmec) genes and the staphylococcal superantigenic toxin genes by multiplex polymerase chain reactions. The MRSA isolates were classified into SCCmec type II (74.8%), type I (13.0%), type IV (3.8%), type V (2.3%), and type I and type II (3.8%). MRSA isolates (102/131) also carried a number of superantigenic toxin genes including staphylococcal enterotoxin (se) and toxic shock syndrome toxin-1 (tst-1) genes. The most frequent superantigen gene profile (55/131, 42.0%) of the MRSA isolates includes staphylococcal enterotoxin C (sec), seg, sei, staphylococcal enterotoxin-like L (sell), selm, seln, selo, and tst-1. Furthermore, SCCmec type I or type II MRSA isolates more frequently harbor sec, seg, sei, sell, selm, seln, selo, and tst-1 genes, compared to other types of MRSA. These results indicate that the selected superantigenic toxin genes are linked to SCCmec type I and type II. The coexistence of these toxins and the SCCmec genes in S. aureus may contribute to the biological fitness and pathogenicity of MRSA.
Staphylococcus aureus is a leading cause of human disease in the hospital setting as well as in the community accounting for a wide range of diseases from superficial skin infections to life-threatening conditions such as bacteremia, endocarditis, pneumonia and toxic shock syndrome (Lowy 1998; Hallin et al. 2007) . Infections with S. aureus are especially difficult to treat because of evolved resistance to antimicrobial drugs. The emergence of S. aureus strains resistant to methicillin (MRSA) and other antimicrobial agents has become a major concern, especially in the hospital environment, because of the higher mortality due to systemic MRSA infections (Klein et al. 2007 ). Methicillin resistance in S. aureus is due to the acquisition of an altered penicillin-binding protein PBP2a (PBP2'), encoded by the mecA gene (Beck et al. 1986; Katayama et al. 2000) , which is carried by a mobile genetic element called staphylococcal cassette chromosome mec (Archer et al. 1996; Wu et al. 1996) . Different SCCmec types have been recognized, which vary in size from 21 to 67 kb, and have different sets of ccr recombinase genes (Oliveira et al. 2006; Berglund and Soderquist 2008; Zhang et al. 2009 ). Some of the mecA elements contain DNA from other species of staphylococci and it has been hypothesized that these mecA elements are mobile and have been passed from methicillin resistant coagulase-negative Staphylococcus spp. to S. aureus, creating MRSA isolates (Eady et al. 2003) . Multidrug-resistant MRSA are usually associated with hospital isolates that may also be resistant to aminoglycoside, sulfamethoxazole and trimethoprim (Novotna et al. 2005) . Analysis of the natural population dynamics and expansion of pathogenic clones of S. aureus provided evidence that essentially any S. aureus genotype carried by humans can transform into a life-threatening human pathogen but that certain clones are more virulent than others (Melles et al. 2004) .
Many S. aureus strains, especially MRSA, produce one or more specific staphylococcal superantigenic toxins, including staphylococcal enterotoxins (SEs), enterotoxinlike superantigens and toxic shock syndrome toxin 1 (TSST-1) . These toxins can bypass normal antigen presentation and have strong T cell mitogenic activity by direct binding to the Vβ region of specific T cells and the major histocompatibility complex class II molecules of antigen presenting cells (Llewelyn and Cohen 2002) . This leads to a massive release of proinflammatory cytokines and contributes to the severity of S. aureus sepsis (McCormick et al. 2001; Holtfreter and Broker 2005) . To date, 21 SEs have been identified based on sequence homologies (Becker et al. 2003; Ono et al. 2008) . Although a few clinical studies have attempted to correlate toxic shock and outcome with the presence of certain SEs in patients with S. aureus infections (Kravitz et al. 2005; Ferry et al. 2008) , the contribution of these toxins to outcome is still unclear. With new data emerging implicating SEs in the pathogenesis of chronic allergic syndromes, production of monoclonal antibodies and vaccine strategies targeting SEs may be considered (Bonventre et al. 1988; LeClaire et al. 2002; Hu et al. 2003; Kansal et al. 2007 ) in the future. It is therefore important to characterize the prevalence of SE and SCCmec genes in clinical S. aureus strains. The purpose of the present study was to investigate the characterization and concomitant subtyping of SCCmec types, and the presence of the superantigenic toxin genes in MRSA collected from different patients during 2004 to 2009 with recently developed novel multiplex PCR assays, and to correlate them with SCCmec and superantigenic toxin gene profiles.
Materials and Methods

Bacterial strains and isolates
A total of 131 MRSA clinical strains were isolated from clinical patients in Hirosaki University Hospital, Japan, during 2004 to 2009. Of these, 33 strains were isolated from expectoration, 22 strains were from cellulitis and abscess, 14 strains were from pharynx viscous liquid, and other strains were isolated from feces and urine (9 strains), blood (13 strains), absorption slime in lung (3 strains), cannula (7 strains), discharge from ear (9 strains), wound (6 strains) and nasal cavity (15 strains). Each sample was plated onto a trypticase soy agar plate with 5% defibrinated sheep blood (blood agar; Nissui Pharmaceutical Co, Ltd., Tokyo, Japan) and incubated at 37°C for 24 h. S. aureus was identified by standard microbiological methods, including Gram staining, the catalase test, the latex slide agglutination test for clumping factor and protein A (PS test; Eiken Chemistry Co. Ltd., Tokyo, Japan), and the tube coagulase test. The strains were stocked in trypticase soy broth with 15% glycerol at −80°C until use. Eleven reference strains for SE gene typing including full genome sequncing strains (N315; DDB/GenBand/EMBL BA000018, Mu50; BA000017, MW2; BA000033) were used in this study (Omoe et al. 2005 (Ito et al. , 2004 Ma et al. 2002; Okuma et al. 2002) . Twenty of methicillin-sensitive S. aureus (MSSA) were used as negative controls for mecA.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed with the Pos Combo Panel Type 2J, and the results were read on a WalkAway System (Dade Behring Inc., West Sacramento, Calif.). The antibiotics tested were gentamicin (GEN), erythromycin (ERY), clindamycin (CLI), ofloxacin (OFX), vancomycin (VAN), and trimethoprim-sulfamethoxazole (SXT). The isolates were interpreted as sensitive or resistant according to the MICs. Resistance to several drugs was determined by plating on tryptic soy agar (TSA) already containing antibiotics. After a 24-h incubation, growth of more than two colonies was determined as resistance. In addition, resistance to methicillin was detected on oxacillin resistance screening agar medium (Mueller-Hinton oxacillin) and was confirmed by screening for penicillin-binding protein 2a (Slidex MRSA detection; Denka Seiken) (Murakami et al. 1991) .
Multiplex PCR for detection and typing of SCCmec genes
SCCmec type-and subtype-unique and specific primers, as well as the specific primers for mecA genes (Table 2) were designed based on the comprehensive analyses and alignments of the S. aureus and MRSA genomes and SCCmec sequences currently available in the GenBank database (Zhang et al. 2005) . The oligonucleotide primers used in this study were synthesized and purchased from Greiner Japan (Greiner bio-one, Tokyo, Japan). Genomic S. aureus DNA was purified using a QIA-amp DNA purification kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer's instructions and then used for PCR amplification of SCCmec genes. SCCmec multiplex PCR (M-PCR) typing assay contained 9 pairs of primers including the unique and specific primers for SCCmec types and subtypes I, II, III, IVa, IVb, IVc, IVd, and V, and the primers for the mecA gene ( Table  2 ). The M-PCR assay used for characterization of mec gene contained 4 primers each (mecI-F, mecI-R, IS1272-F and mecR1-R for mec gene M-PCR). All PCR assays were performed directly from bacterial suspensions obtained after the rapid DNA extraction method. An aliquot of 2 µl of this suspension was added to 23 µl of PCR mixture containing 50 mM KCl, 20 mM Tris-HCl (pH 8.4), 2.5 mM MgCl 2 , 0.2 mM of each deoxynucleoside triphosphate(GeneAmp dNTP, Applied Biosystems, Tokyo, Japan), various concentrations of the respective primers (Table 2) , and 1.0 unit of Ampli Taq Gold polymerase (Applied Biosystems). The amplification was performed in a iCycler (Bio-Rad, Tokyo, Japan) beginning with an initial denaturation step at 94°C for 5 min followed by 10 cycles of 94°C for 45 seconds, 65°C for 45 seconds, and 72°C for 1.5 min and another 25 cycles of 94°C for 45 seconds, 55°C for 45 seconds, and 72°C for 1.5 min, ending with a final extension step at 72°C for 10 min and followed by a hold at 4°C. For the single target amplification, PCR was run in 23 µl of PCR mixture but containing 0.2 µM of each primer, with cycling parameters beginning with an initial denaturation step at 94°C for 5 min followed by 30 cycles of 94°C for 1 min, 50°C for 1 min, and 72°C for 2 min, ending with a final extension step at 72°C for 10 min. All PCR assay runs incorporated a reagent control (without template DNA). The PCR amplicons were visualized on a transilluminator after electrophoresis on a 2% agarose gel and stained by 0.5 µg/ml ethidium bromide.
Detection and typing of se and tst genes
Genomic S. aureus DNA was purified using a QIA-amp DNA purification kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer's instructions and then used for PCR amplification of superantigen genes. The nucleotide sequences of 19 PCR primers and their respective amplified products were described previously (Omoe et al. 2005) . The primer sets were designed to anneal to unique regions and generate amplicons that would allow identification of each se or tst gene based on the molecular weight of its PCR product. To construct a multiplex PCR system, four sets (Set 1: sea, seb, sec, sed, see, femB; Set 2: seg, she, sei, selj, selp, femA; Set 3: selk, selm, selo, femA; Set 4: sell, seln, selr, femB) of 10 × primer master mixes containing 2 mM of each primer were prepared. Multiplex PCR was performed with QIAGEN multiplex PCR kit (QIAGEN) according to manufacturer's instructions. DNA amplification was carried out with the following thermal cycling profile: an initial denaturation of DNA and QIAGEN HotStartTaq DNA polymerase activation at 95°C for 15 min was followed by 35 cycles of amplification (95°C for 30 s, 57 °C for 90 s, and 72°C for 90 s), ending with a final extension at 72°C for 10 min. PCR products were resolved by electrophoresis in a 3% NuSieve 3:1 agarose gel (Cambrex Bio Science Rockland, Inc., Rockland, ME) in 0.5 × TBE (Tris-boric acid-EDTA) buffer, stained by 0.5 µg/ml ethidium bromide, and visualized on a transilluminator.
Statistical analysis
The prevalence of the tested genes in MRSA isolates were compared with two tailed Fisher's exact test. A significance level of p ≤ 0.05 was used. MecA147-R ATGCGCTATAGATTGAAAGGAT
Results
Distribution of MRSA isolates among the different departments and body sites
In total, 131 MRSA strains isolated from clinical specimens were under study. The highest proportions of MRSA clones have been isolated from the surgical wards (35.1%) and the department of internal medicine (13.7%). In contrast, the highest proportions of MSSA clones have been isolated from the pediatrics wards (32.1%), the department of internal medicine (14.3%) and otolaryngology (14.3%). The patients with MRSA infection or colonization were older than patients with MSSA infection. The distributions of MRSA and MSSA in various body sites were similar among the patient groups that infected with MRSA or MSSA.
Prevalence of SCCmec genes in MRSA
Uniplex PCR using each primer set with total DNA of reference MRSA strains was performed: S. aureus NCTC10442 total DNA for type I, N315 for type II, 85/2082 for type III, CA05 for type IVa, 8/6-3P for type IVb, MR108 for type IVc, JCSC4469 for type IVd, and WIS [WBG8318]-JCSC3624) for type V (Table 1 ). The sizes of PCR products obtained by these uniplex PCRs were identical to those predicted from the design of the primers.
The combinations of primer sets and reaction conditions for the multiplex PCR were optimized to ensure that all PCR products of target genes were satisfactorily amplified. We ultimately constructed three optimized multiple primer sets. Reliable amplification of PCR products was observed in all multiplex PCR reactions using the three primer sets. The sizes of the PCR products obtained from the positive control and the reference strains corresponded to their predicted sizes (Fig. 1) . A total of 131 MRSA isolates from clinic specimens were subjected to genotyping analysis of SCCmec genes. All of the MRSA isolates tested harbored the mecA genes. The 131 MRSA isolates were classified into SCCmec type II, the highest proportion (98/131, 74.8% strains) of SCCmec gene, and then type I (13.0%), type IV (3.8%), type V (2.3%), and type I and type II (3.8%) (Fig.  2) .
Prevalence of superantigenic toxin genes in MRSA
We recently developed a comprehensive detection system for 18 kinds of classical and newly described staphylococcal superantigenic toxin genes using four sets of multiplex PCR (Omoe et al. 2005) . Of the 131 MRSA isolates, all the isolates tested harbored the femA and femB genes. These MRSA isolates were diagnosed as positive for superantigenic toxin genes and a total of 23 superantigenic toxin genotypes were detected among the MRSA isolates ( 3). At least one superantigenic toxin gene was detected in all the MRSA strains and most (128 of 131) strains contained more than one superantigenic toxin gene. The most abundant superantigenic toxin was seo, which was found in 92% of the MRSA isolates. The prevalence of individual superantigenic toxin genes was variable and was as follows:
The highest proportion (42.0%, 55 /131 strains) of toxin gene profile was sec, seg, sei, sell, selm, seln, selo, and tst-1 (Table 3) . Of the MRSA isolates, 41.2 and 18.3% contained eight and nine superantigen genes, respectively. Twenty-four strains contained 10 or 11 superantigen genes. These gene profiles were mainly due to the fixed combinations of seg, sei, selm, seln, and selo (Table 3) .
Association of SCCmec genotypes with superantigenic toxin genotypes in MRSA
Several mechanisms of antimicrobial resistance have been described in S. aureus, mostly involving the acquisition of plasmids. We further analyzed the association of SCCmec genotypes and frequency of superantigenic toxin genes in the MRSA isolates. Results showed that sec, seg, sei, sell, selm, seln, selo and tst-1 genes were detected exclusively in the SCCmec type I and Type II MRSA isolates (Table 3 and Fig. 3 ). Of the SCCmec type II MRSA, 77.4% (79/98) of the isolates harbored sec, sell and tst-1 genes which are associated with the mobile genetic element, type I vSa4, and 47.0% (48/98) of them harbored sec, sell, tst-1 and the combination genes (seg, sei, selm, seln, and selo) which are encoded by type I vSaβ (Fig. 3) . No sec and tst genes were determined in the SCCmec type IV and type V isolates.
Discussion
This study is the first cross-sectional and comprehensive comparison of SCCmec genes and the classical and newly described superantigen genes of MRSA isolates by two multiplex PCR systems. Our results showed that the main SCCmec gene was type II and there are many superantigenic toxin genotypes in the MRSA isolates from clinical specimens. Seventy-five percent of the MRSA isolates carried SCCmec type II gene and 13.0% of the MRSA carried SCCmec type I. Of the SCCmec type II MRSA, 77.4% of the isolates harbored sec, sell and tst-1 genes which are associated with the mobile genetic element, Type I vSa4, and 47.0% of them harbored sec, sell, tst-1 and the combination genes (seg, sei, selm, seln, and selo) which are encoded by Type I vSaβ, an enterotoxin gene cluster locus.
SCCmec typing is one of the most important molecular tools for exploring the epidemiology and evolution of MRSA (Deurenberg and Stobberingh 2008; Chen et al. 2009) . A number of PCR-based methods to determine the structure of SCCmec complex and the presence of the different ccr genes have been developed over the past several years Okuma et al. 2002; Oliveira and de Lencastre 2002 ). An easy-to-use multiplex PCR assay for the determination of the structure of SCCmec type I to V have been developed (Zhang et al. 2005; Boye et al. 2007) and are reviewed extensively and updated recently (Milheirico et al. 2007; Deurenberg and Stobberingh 2008) . In this study, we established three multiplex PCR reaction sets to determine the SCCmec genes of the MRSA isolates and showed that this multiplex PCR is specific for the target gene and is a rapid characterization method for SCCmec typing. Our results showed that 74.8% of MRSA isolates Total DNA of S. aureus was purified and 3 primer sets of SCCmec genes based on the molecular weight of its PCR product were used to anneal to unique regions and generate amplicons. The number of positive genes in each isolate was recorded and the percentage was calculated with the total isolates. NT: can not typed.
tested carried SCCmec type II gene and 13.0% of the MRSA carried SCCmec type I, indicating that SCCmec type II is a main SCCmec type in Japan. An MRSA strain with SCCmec type II was discovered in Japan in 1982 and this so-called New York/Japan clone spread worldwide (Deurenberg and Stobberingh 2008) . SCCmec type III, discovered in New Zealand in 1985, was not detected in this study.
Besides the resistance genes on SCCmec, S. aureus can carry resistance genes inserted at other sites of the chromosome and on plasmids. SCCmec also carries insertion sequences as will as genes responsible for the regulation of mecA transcription Deurenberg et al. 2007 ). Toxin-producing S. aureus may alter the pathogenicity of established MRSA by the transfer of virulence factors via plasmids or mobile elements. Charactering the clinically relevant MRSA and testing for classical and newly described se, se-like and tst superantigen genes provide additional information for epidemiological data analysis . Chini et al. (2006) had shown that 60 of 177 MRSA isolates were positive for at least one of the superantigen genes. Omoe et al. (2005) also reported that all strains originating from food poisoning were positive for se genes and 79.4% of isolates from healthy human nasal swabs were positive for se and/or tst genes. Most of the diseases induced by S. aureus are caused by specific toxins whose genetic determinants are frequently carried by potentially mobile elements such as plasmids, phages, or pathogenicity islands (Kuroda et al. 2001; Jarraud et al. 2002) . Expression of virulent genes in S. aureus is controlled by the accessory gene regulator (agr), with a polymorphism in the sequence of the autoinducing peptide and its receptor (Jarraud et al. 2002; Lina et al. 2003) . Genomic island allotyping was mentioned to be a useful approach to S. aureus genotyping and that this process would enable the prediction of the pathogenic capability of S. aureus clinical strains (Baba et al. 2002) . The present study showed that all MRSA isolates tested carried a number of toxin genes, ranging from two to eleven, with an extensive variation between individual strains and suggest that our multiplex PCR system for comprehensively detecting superantigenic toxin genes would be useful in determining genomic island allotypes. The role of SEs, especially the recently described SEs, in increasing acquisition of resistance against antibiotics and in toxin-mediated staphylococcal diseases still remains unclear. Our results showed that 77.4% of the SCCmec type II MRSA isolates harbored sec, sell, tst-1 and the combination genes (seg, sei, selm, seln, and selo) or in further combinations with other toxin genes. These results suggest (A) Total DNA of S. aureus was purified and 4 primer sets were used to anneal to unique regions and generate amplicons that allow identification of each se or tst gene based on the molecular weight of its PCR product. Overall numbers of each toxin gene in MRSA were recorded and the percentage was calculated with the total isolates. ND: not detected.
(B) Percentage of mobile genetic elements in MRSA isolates. Mobile genetic elements encoding superantigenic toxin gene were analyzed according to the data in Table 3 .
that these MRSA isolates mainly are the New York/Japan clone, that with multilocus sequence type 5, agr type 2 and SCCmec II, and possesses both the tst and sec genes (Zaraket et al. 2007 ). The combination genes (seg, sei, selm, seln, and selo) encoded by egc was incomplete in a few strains of the SCCmec type II, suggesting the egc locus was incomplete and occasionally harbored an insertion sequence and transposase genes. These strains may represent evolutionary intermediates of the egc locus (Thomas et al. 2006) . Analysis of the relationship among SCCmec and toxin genotypes and toxin genes encoding profiles of mobile genetic elements has a possible role in determining superantigenic toxin genotypes in S. aureus. Since frequent horizontal transfer of SCCmec and other mobile genetic elements seem to be the source of the ongoing genetic diversification of MRSA (Robinson and Enright 2003; Lindsay et al. 2006; Hallin et al. 2007) , comparative prevalence studies of large MRSA populations should be conducted in parallel with MRSA surveillance studies, to understand how natural populations of MSSA and MRSA co-evolve and interact.
